Growth Metrics

Standard Biotools (LAB) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn 1,019.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,019.85%
Dec 31, 2025 79.91%
Sep 30, 2025 50.65%
Jun 30, 2025 140.48%
Mar 31, 2025 -106.66%
Dec 31, 2024 -52.06%
Sep 30, 2024 6.00%
Jun 30, 2024 -159.75%
Mar 31, 2024 634.53%
Dec 31, 2023 -235.52%
Sep 30, 2023 -350.30%
Jun 30, 2023 -35.81%
Mar 31, 2023 1,885.84%
Sep 30, 2022 64.59%
Jun 30, 2022 218.27%
Mar 31, 2022 108.58%
Sep 30, 2021 -235.03%
Jun 30, 2021 -581.95%
Mar 31, 2021 -248.87%
Dec 31, 2020 3.80%
Sep 30, 2020 1,495.00%
Jun 30, 2020 119.86%
Mar 31, 2020 142.58%
Dec 31, 2019 -107.23%
Sep 30, 2019 153.50%
Jun 30, 2019 -1,681.56%
Mar 31, 2019 -80.28%
Dec 31, 2018 2,052.42%
Sep 30, 2018 -115.95%
Jun 30, 2018 53.31%
Mar 31, 2018 -283.00%
Dec 31, 2017 -199.77%
Sep 30, 2017 718.59%
Jun 30, 2017 31.49%
Mar 31, 2017 -32.81%
Dec 31, 2016 499.21%
Sep 30, 2016 -167.23%
Jun 30, 2016 47.83%
Mar 31, 2016 235.17%
Dec 31, 2015 -83.91%
Sep 30, 2015 142.08%
Jun 30, 2015 76.84%
Mar 31, 2015 -93.91%
Dec 31, 2014 -79.18%
Sep 30, 2014 0.80%
Jun 30, 2014 -94.47%
Mar 31, 2014 1,904.91%
Dec 31, 2013 305.59%
Sep 30, 2013 -121.91%
Jun 30, 2013 -2,131.82%
Mar 31, 2013 164.14%
Dec 31, 2012 -550.18%
Sep 30, 2012 3,179.36%
Jun 30, 2012 103.17%
Mar 31, 2012 -110.20%
Dec 31, 2011 204.46%
Sep 30, 2011 156.27%